论文部分内容阅读
目的了解本院在当前招标模式下的采购现状,存在的问题及原因,以期找到一些应对的措施与方法。方法对本院2015年度竞价报量的12期基本药物及非基本药物医保品种数量进行统计,包括报量数目及报量中标的数目。将从广东省药品电子交易平台提取出本院2015年度签订的竞价及议价合同及所涉及的品种进行统计分析,统计内容包括药品的价格、合同的履行情况等。结果竞价品种无论基本药物还是非基医保品种均在报量,报量中标率最高100%,最低仅为29%,平均为72.28%。部分药物纳入采购困难品种及临床必需目录后购入成本升高;部分竞价药品价格低廉,药品质量令人担忧。生效合同在发订单后履行状态欠佳,供货不及时是常态。结论广东省当前的招标模式是新生事物,总会存在一些问题,如果药品定价合理,完善招标政策及药品供应链,加强短缺药品的预警与管理,可减少药品短缺状况。
Objective To understand the status quo of purchasing, the existing problems and the reasons of this hospital under the current bidding mode in order to find some measures and methods to deal with it. Methods Statistics on the number of 12 kinds of basic medicines and non-essential medicines covered by our hospital’s bidding in 2015, including the number of quotations and the number of successful bidders. The auction and bargaining contracts signed by the hospital in 2015 and the varieties involved will be extracted from the Guangdong Pharmaceutical Electronic Trading Platform for statistical analysis. The statistical contents include the price of the drugs and the performance of the contract. As a result, bid-winning varieties, both basic medicines and non-basic medical insurance varieties, were reported at the rate of 100%, the lowest bidding rate was only 29% and the average was 72.28%. Some drugs into the purchase of difficult varieties and clinically necessary list of costs increased after the purchase; part of the auction price of medicines is low, the quality of medicines is cause for concern. The effective contract in the performance of orders after the poor performance, delivery is not normal is the time. Conclusion Guangdong’s current bidding model is newborn. There are always some problems. If drug pricing is reasonable, improving the bidding policy and drug supply chain, and strengthening the early warning and management of shortage medicines, the shortage of medicines can be reduced.